Cargando...
Dengue vaccine development: status and future
Dengue, the most common arbovirus, represents an increasingly significant cause of morbidity worldwide, including in travelers. After decades of research, the first dengue vaccine was licensed in 2015: CYD-TDV, a tetravalent live attenuated vaccine with a yellow fever vaccine backbone. Recent analys...
Guardado en:
| Publicado en: | Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Springer Berlin Heidelberg
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7224137/ https://ncbi.nlm.nih.gov/pubmed/31784763 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00103-019-03060-3 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|